First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort. Lewis H, Kiss A, Ramani P, Parkey A, Haire J, Samanta D, Ramakrishnaiah R, Willis E J Child Neurol. 2026 Jun 02:8830738261452770. PMID: 42227196. Abstract CommentRecommendBookmarkWatch
